Video

Medicare Part D and Oncology

Author(s):

Lauren Santye, Assistant Editor

Marc O'Connor, COO and chief strategy officer at Curant Health, discusses how the shift to Medicare Part D could impact patients undergoing treatment for cancer.

Marc O'Connor, COO and chief strategy officer at Curant Health, discusses how the shift to Medicare Part D could impact patients undergoing treatment for cancer.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit: Artur | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Image credit: AwieDarwis | stock.adobe.com
Image credit: viperagp | stock.adobe.com
Image credit: kitsawet | stock.adobe.com
Related Content
Visualization of plasma cell in multiple myeloma | Image Credit: © ArtificialHorizons - stock.adobe.com
July 8th 2025

IsaKRD Induction Achieves 95% Response Rate in Multiple Myeloma

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Immune marker Assesses globulin levels, elevated in cancers
July 7th 2025

FDA Approves Immunoglobulin Formulation With Low IgA Content for Primary Immunodeficiency

Luke Halpern, Assistant Editor
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
FDA headquarters -- Image credit: Tada Images | stock.adobe.com
July 7th 2025

Sebetralstat Becomes First and Only FDA-Approved Oral, On-Demand Treatment for HAE

Gillian McGovern, Associate Editor
Building a Sustainable Pharmacogenomics Program: A Pharmacist’s Perspective at Ochsner Health
July 7th 2025

Building a Sustainable Pharmacogenomics Program: A Pharmacist’s Perspective at Ochsner Health

Serena Mitaly, PharmD Alana Hippensteele, Lead Editor